Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

Linezolid is an oxazolidinone used to treat multidrug-resistant tuberculosis (MDR-TB), including in the recently-endorsed shorter 6-month treatment regimens. Due to its narrow therapeutic index, linezolid is often either dose-adjusted or discontinued due to intolerance or toxicity during treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Resendiz-Galvan, Juan Eduardo, Arora, Prerna R., Abdelwahab, Mahmoud Tareq, Udwadia, Zarir F., Rodrigues, Camilla, Gupta, Amita, Denti, Paolo, Ashavaid, Tester F., Tornheim, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846493/
https://www.ncbi.nlm.nih.gov/pubmed/36686664
http://dx.doi.org/10.3389/fphar.2022.1081123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846493/
https://www.ncbi.nlm.nih.gov/pubmed/36686664
http://dx.doi.org/10.3389/fphar.2022.1081123

Ejemplares similares